|
End-of-day quote
Borsa Italiana
20/08/2026
|
5-day change | 1st Jan Change | ||
| 121.62 EUR | -0.30% |
|
-8.07% | -27.63% |
| 19/08 | Oracle Health Expands Clinical AI Agent With New AI Documentation Capabilities | MT |
| 19/08 | Oracle Health Announces New Capabilities For Oracle Health Clinical AI Agent In The U.S | CI |
Company Valuation: Oracle Corporation
Data adjusted to current consolidation scope
| Fiscal Period: May | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,91,894 | 2,86,017 | 3,22,098 | 4,64,185 | 6,49,354 | 4,21,903 | - | - |
| Change | - | 49.05% | 12.62% | 44.11% | 39.89% | -35.03% | - | - |
| Enterprise Value (EV) 1 | 2,45,851 | 3,66,311 | 3,98,306 | 5,45,550 | 7,47,001 | 5,54,013 | 5,87,561 | 5,99,743 |
| Change | - | 49% | 8.73% | 36.97% | 36.93% | -25.84% | 6.06% | 2.07% |
| P/E | 29.8x | 34.5x | 31.6x | 38.1x | 38.7x | 22.9x | 16.4x | 11.2x |
| PBR | -34.7x | 268x | 34.9x | 22x | 15.3x | 5.04x | 3.6x | 2.99x |
| PEG | - | 1.3x | 1.5x | 2.2x | 1.1x | 2.36x | 0.4x | 0.2x |
| Capitalization / Revenue | 4.52x | 5.73x | 6.08x | 8.09x | 9.64x | 4.72x | 3.23x | 2.32x |
| EV / Revenue | 5.79x | 7.33x | 7.52x | 9.5x | 11.1x | 6.2x | 4.5x | 3.29x |
| EV / EBITDA | 11.4x | 15.6x | 15.2x | 18.9x | 20.4x | 11.1x | 8.16x | 5.65x |
| EV / EBIT | 12.5x | 17.5x | 17.3x | 21.8x | 25.8x | 15.4x | 12.1x | 8.96x |
| EV / FCF | 48.9x | 43.2x | 33.7x | -1,385x | -31.5x | -11.6x | -13.9x | 43.5x |
| FCF Yield | 2.05% | 2.31% | 2.96% | -0.07% | -3.17% | -8.62% | -7.21% | 2.3% |
| Dividend per Share 2 | 1.28 | 1.36 | 1.6 | 2 | 2 | 2.04 | 2.153 | 2.388 |
| Rate of return | 1.78% | 1.28% | 1.37% | 1.21% | 0.89% | 1.39% | 1.47% | 1.63% |
| EPS 2 | 2.41 | 3.07 | 3.71 | 4.34 | 5.83 | 6.396 | 8.93 | 13.13 |
| Distribution rate | 53.1% | 44.3% | 43.1% | 46.1% | 34.3% | 31.9% | 24.1% | 18.2% |
| Net sales 1 | 42,440 | 49,954 | 52,961 | 57,399 | 67,357 | 89,337 | 1,30,637 | 1,82,039 |
| EBITDA 1 | 21,565 | 23,428 | 26,184 | 28,900 | 36,549 | 49,996 | 71,963 | 1,06,132 |
| EBIT 1 | 19,593 | 20,902 | 23,055 | 25,033 | 28,926 | 35,897 | 48,589 | 66,900 |
| Net income 1 | 6,717 | 8,503 | 10,467 | 12,443 | 16,984 | 19,063 | 27,626 | 42,316 |
| Net Debt 1 | 53,957 | 80,294 | 76,208 | 81,365 | 97,647 | 1,32,110 | 1,65,658 | 1,77,841 |
| Reference price 2 | 71.92 | 105.94 | 117.19 | 165.53 | 225.78 | 146.47 | 146.47 | 146.47 |
| Nbr of stocks (in thousands) | 26,68,157 | 26,99,802 | 27,48,514 | 28,04,234 | 28,76,046 | 28,80,471 | - | - |
| Announcement Date | 13/06/22 | 12/06/23 | 11/06/24 | 11/06/25 | 10/06/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 22.9x | 6.2x | 11.08x | 1.39% | 42TCr | |
| 26.71x | 5.34x | 16.79x | 1.42% | 25TCr | |
| 83.17x | 8.09x | 21.65x | -.--% | 13TCr | |
| 37.85x | 3.55x | 13.06x | 0.18% | 4.68TCr | |
| -60.28x | 97.92x | 843.93x | -.--% | 4.58TCr | |
| 31.07x | 12.04x | 19.66x | -.--% | 2.53TCr | |
| 38.61x | 2.56x | 23.33x | -.--% | 2.12TCr | |
| 108.59x | 10.42x | 44.42x | -.--% | 1.58TCr | |
| -648.41x | 3.84x | 12.85x | - | 1.4TCr | |
| Average | -39.98x | 16.66x | 111.86x | 0.37% | 10.86TCr | |
| Weighted average by Cap. | 21.18x | 10.52x | 54.20x | 0.99% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ORCL Stock
- 1ORCL Stock
- Valuation Oracle Corporation
Select your edition
All financial news and data tailored to specific country editions
